全文获取类型
收费全文 | 10943篇 |
免费 | 528篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 185篇 |
儿科学 | 150篇 |
妇产科学 | 78篇 |
基础医学 | 1192篇 |
口腔科学 | 137篇 |
临床医学 | 629篇 |
内科学 | 3028篇 |
皮肤病学 | 444篇 |
神经病学 | 720篇 |
特种医学 | 459篇 |
外科学 | 2234篇 |
综合类 | 50篇 |
预防医学 | 300篇 |
眼科学 | 202篇 |
药学 | 522篇 |
中国医学 | 23篇 |
肿瘤学 | 1201篇 |
出版年
2023年 | 68篇 |
2022年 | 120篇 |
2021年 | 252篇 |
2020年 | 143篇 |
2019年 | 190篇 |
2018年 | 253篇 |
2017年 | 222篇 |
2016年 | 245篇 |
2015年 | 264篇 |
2014年 | 332篇 |
2013年 | 423篇 |
2012年 | 634篇 |
2011年 | 708篇 |
2010年 | 408篇 |
2009年 | 317篇 |
2008年 | 639篇 |
2007年 | 694篇 |
2006年 | 654篇 |
2005年 | 666篇 |
2004年 | 624篇 |
2003年 | 632篇 |
2002年 | 628篇 |
2001年 | 198篇 |
2000年 | 186篇 |
1999年 | 212篇 |
1998年 | 143篇 |
1997年 | 103篇 |
1996年 | 98篇 |
1995年 | 91篇 |
1994年 | 74篇 |
1993年 | 56篇 |
1992年 | 113篇 |
1991年 | 88篇 |
1990年 | 101篇 |
1989年 | 114篇 |
1988年 | 93篇 |
1987年 | 76篇 |
1986年 | 75篇 |
1985年 | 55篇 |
1984年 | 44篇 |
1983年 | 41篇 |
1982年 | 24篇 |
1981年 | 24篇 |
1979年 | 32篇 |
1975年 | 28篇 |
1973年 | 36篇 |
1970年 | 25篇 |
1969年 | 34篇 |
1968年 | 33篇 |
1967年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
91.
Yamanaka H Teruya K Tanaka M Kikuchi Y Takahashi T Kimura S Oka S;HIV/Influenza Vaccine Study Team 《Journal of acquired immune deficiency syndromes (1999)》2005,39(2):167-173
Influenza vaccine is recommended for HIV-1-infected patients. The present prospective study was conducted to evaluate the clinical efficacy and immunologic responses to the vaccine. From November 1 to December 27, 2002, 262 HIV-1-infected patients received a trivalent influenza subunit vaccine, whereas 66 did not. Influenza illness occurred in 16 vaccinated and 14 nonvaccinated patients (incidence = 6.1% [95% confidence interval (CI): 4%-10%] in vaccinated vs. 21.2% [CI: 13%-35%] in nonvaccinated persons, P < 0.001; relative risk = 0.29 [CI: 0.14-0.55]). Influenza vaccine provided clinically effective protection against influenza illness in HIV-1-infected patients. In baseline antibody-negative patients, anti-H1 and anti-H3 antibody responses to the vaccination were significant in those patients with a CD4 count >200 cells/muL compared with those with a CD4 count <200 cells/muL (P < 0.05). In contrast, in baseline antibody-positive patients, good antibody responses were observed irrespective of CD4 counts, like the healthy controls. Based on these results, annual vaccination is recommended. Specific CD4 responses correlated with HIV-1 viral load (VL), especially in patients treated with highly active antiretroviral therapy (HAART) compared with those without HAART (P < 0.01), although the clinical efficacy did not correlate with HIV-1 VL. HAART may enhance the immunologic efficacy of influenza vaccine. 相似文献
92.
93.
94.
Takahiro Yamanaka Kenyu Nakayama-Iwatsuki Sora Fujimoto Naoki Hirono Jun Negishi Yasushi Tamada Masumi Hirabayashi Shinichi Hochi 《Transplantation proceedings》2021,53(5):1744-1750
Islet transplantation is a promising option for the clinical treatment of insulin-dependent diabetes, but a reliable islet cryopreservation/transplantation protocol should be established to overcome the donor shortage. The current study reports that a silk fibroin (SF) sponge disk can be used as a cryodevice for vitrification of large quantity pancreatic islets and the scaffold for subsequent subrenal transplantation in a rat model. The marginal islet mass (550 islet equivalents [IEQs]) on an SF sponge disk was vitrified-warmed and transplanted beneath the kidney capsule of a streptozotocin-induced diabetic rat with or without vascular endothelial growth factor (VEGF). Subrenal transplantation (no scaffold) of 550 IEQ fresh islets and post-warm islets vitrified on a nylon mesh device resulted in achieving euglycemia of recipient rats at 60% and 0%, respectively. Transplantation of 550 IEQ islets vitrified-warmed on an SF sponge disk failed to achieve euglycemia of recipient rats (0%), but the VEGF inclusion in the SF sponge disk contributed to acquiring the euglycemic recipients (33%). All cured recipient rats regained hyperglycemia after nephrectomy, and the histopathologic analysis exhibited a well-developing blood vessel network into the islet engrafts. Thus, an SF sponge disc was successively available as the cryodevice for islet vitrification, the transporter of the angiogenic VEGF, and the scaffold for subrenal transplantation in the rat model. 相似文献
95.
96.
97.
Koichi Yasuda Hideki Minatogawa Yasuhiro Dekura Seishin Takao Masaya Tamura Nayuta Tsushima Takayoshi Suzuki Satoshi Kano Takatsugu Mizumachi Takashi Mori Kentaro Nishioka Motoyasu Shido Norio Katoh Hiroshi Taguchi Noriyuki Fujima Rikiya Onimaru Isao Yokota Keiji Kobashi Shinichi Shimizu Akihiro Homma Hiroki Shirato Hidefumi Aoyama 《Journal of radiation research》2021,62(2):329
Pharyngeal cancer patients treated with intensity-modulated proton therapy (IMPT) using a model-based approach were retrospectively reviewed, and acute toxicities were analyzed. From June 2016 to March 2019, 15 pharyngeal (7 naso-, 5 oro- and 3 hypo-pharyngeal) cancer patients received IMPT with robust optimization. Simulation plans for IMPT and intensity-modulated X-ray therapy (IMXT) were generated before treatment. We also reviewed 127 pharyngeal cancer patients with IMXT in the same treatment period. In the simulation planning comparison, all of the normal-tissue complication probability values for dysphagia, dysgeusia, tube-feeding dependence and xerostomia were lower for IMPT than for IMXT in the 15 patients. After completing IMPT, 13 patients completed the evaluation, and 12 of these patients had a complete response. The proportions of patients who experienced grade 2 or worse acute toxicities in the IMPT and IMXT cohorts were 21.4 and 56.5% for dysphagia (P < 0.05), 46.7 and 76.3% for dysgeusia (P < 0.05), 73.3 and 62.8% for xerostomia (P = 0.43), 73.3 and 90.6% for mucositis (P = 0.08) and 66.7 and 76.4% for dermatitis (P = 0.42), respectively. Multivariate analysis revealed that IMPT was independently associated with a lower rate of grade 2 or worse dysphagia and dysgeusia. After propensity score matching, 12 pairs of IMPT and IMXT patients were selected. Dysphagia was also statistically lower in IMPT than in IMXT (P < 0.05). IMPT using a model-based approach may have clinical benefits for acute dysphagia. 相似文献
98.
Ichiki M Kunugi H Takei N Murray RM Baba H Arai H Oshima I Okagami K Sato T Hirose T Nanko S 《Psychological medicine》2000,30(3):597-604
BACKGROUND: Many studies have suggested a possible aetiological role for obstetric complications in the development of schizophrenia. We focused on prenatal physical growth in schizophrenia, a contentious issue in the literature. METHODS: We compared gestational age at birth, birth weight (BW) and birth head circumference (BHC) between 312 schizophrenics and 517 controls, and between 187 schizophrenics and their matched healthy siblings. Information on obstetric histories was obtained from the Maternal and Child Health Handbooks (i.e. contemporaneous records). RESULTS: Gestational age at birth was significantly earlier in the schizophrenics than in the controls (P = 0.017). Pre-term birth (gestational age of 36 weeks or less) was more common in schizophrenics than in controls (8.0% v. 3.4%, P = 0.005, odds ratio 2.5). Low BW (2500 g or less) was more frequent in schizophrenics than in controls (9.6% v. 4.6%, P = 0.005, odds ratio 2.2). The schizophrenics had significantly lighter BW (P = 0.0003) and tended to have smaller BHC (P = 0.081) compared with controls. However, multiple regression analysis showed that there was no significant difference in BW or BHC between the schizophrenics and controls when gestational age and maternal weight were controlled. There was no significant difference in BW or BHC between schizophrenics and their siblings, although the schizophrenics tended to be born at earlier gestational age than their siblings. CONCLUSIONS: Our results suggest that prematurity at birth is associated with a risk of developing schizophrenia in adulthood. When gestational age and maternal body weight were allowed for, there was no evidence that schizophrenics tend to have lower mean BW or smaller BHC. 相似文献
99.
100.
Shinichi Izuchi Tohru Terachi Masahiro Sakamoto Tetsuo Mikami Mamoru Sugita 《Current genetics》1990,18(3):239-243
Summary The nucleotide sequences of tRNAAsn (GUU) and tRNATyr (GUA) genes from tomato mitochondria and their flanking regions have been determined. The tomato mitochondrial tRNAAsn gene is located 2.1 kb downstream from the tRNACys gene reported previously (Izuchi and Sugita 1989) and shows a nearly complete identity with the corresponding chloroplast gene. The tRNATyr gene, which shows only 73% homology with the corresponding chloroplast gene, has to be considered a native mitochondrial tRNA gene and is 535 bp from the chloroplast-like tRNAAsn gene on the same strand. Northern hybridization analysis revealed that the three tRNA genes are transcribed in tomato mitochondria. Southern hybridization analysis of tomato, sugar beet, rice and wheat mitochondrial DNAs, with oligonucleotide probes for mitochondrial or chloroplast tRNA genes, demonstrated that the mitochondrial tRNACys gene found in tomato is present in dicot plants but not in monocots. On the other hand, a chloroplast-like tRNACys gene exists in monocot plants. 相似文献